MSD's Gardasil soon to launch far ahead of GSK's Cervarix.
However, MSD Korea already got the KFDA approval of Gardasil for the market launching in coming Sept, far ahead to GSK's Cervaris.
MSD Korea said "All vaccines should be examined by the health authority ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
